Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.




Follow This Show

Stay in the know about new episodes and updates.
CureTalks features leading medical experts in conversation with a panel of patients/advocates about latest research and treatments under development.

Upcoming Broadcasts

The MMRF is pioneering precision medicine initiatives in multiple myeloma. This would help match patients to the most effective therapies based on their genetics and other unique factors. We are talking to Anne Quinn Young of MMRF to review myeloma research initiatives at The MMRF, specifically cover The MMRF CoMMPass Study updates, MMRF Answer Fund program, clinical trials currently recruiting and opportunities that patients can explore to share their data and participate in research efforts to accelerate precision medicine. Featured Expert: Anne Quinn Young, VP The MMRF Patient Panel: Gary Petersen, Jack Aiello, Cynthia Chmielewski, Matt Goldman, Priya Menon RSVP here!
  • by CureTalks
  • in Health
  • 01:30
Reminder Edit Reminder

On-Demand Episodes

Multiple myeloma remains incurable despite improved remissions with novel agents. Relapse eventually occurs in the form of drug-resistant disease that carries a dismal prognosis. Relapse is dependent on stem cell functions. We are... more

Surrogacy is a method of assisted reproduction for people who are either unable to conceive due to medical complications, or any other reason. It is an agreement where a woman agrees to carry a pregnancy for a couple or a person, who will... more

FDA approval of the breakthrough CAR-T cell therapy for cancer brings the first approved gene therapy treatment to the United States. It reprograms the body's own immune system to recognize and kill cancer cells. The therapy... more

In 2017 stem cell transplants remain a key option for treatment of eligible multiple myeloma patients, and in majority of patients it is done as a part of frontline therapy. Research shows that stem cell transplants significantly increases the... more

Most multiple myeloma patients, even those in complete response, may show signs of relapse at some point of time. So, testing and quantifying Minimal Residual Disease (MRD) has become essential to obtain better prognostic... more

Multiparametric MRI (mpMRI) is being considered as a game-changer in prostate cancer treatment and management. Our prostate cancer panel of Mike Scott, Tony Crispino, Allen Edel and Joel Nowak is talking to Dr. Antonio Carlos... more

Male factor infertility accounts for 50% of total cases of troubled conception. Unfortunatley male infertility is not as promptly reported as female infertility which is tracked by Society for Assisted Reproductive Technology database. One... more

The MMRF has built a unique model that provides the only end-to-end solution in cancer research. This model is based on three interrelated pillars fueled by data generation and integration; collaboration and discovery; and accelerating clinical... more

A high risk pregnancy can be life-threatening to the mother as well as the baby. Women must be trained to tell, when they need medical attention themselves, in addition to the baby care training they receive. We are talking to Dr. Shannon... more

Continuing our discussion with Dr. Paul Schellhammer, is Mike Scott and the prostate cancer panel.
Show Extras